Skip to menu Skip to content Skip to footer
Associate Professor David Wyld
Associate Professor

David Wyld

Email: 

Overview

Availability

Associate Professor David Wyld is:
Available for supervision

Works

Search Professor David Wyld’s works on UQ eSpace

201 works between 1998 and 2025

141 - 160 of 201 works

2016

Conference Publication

Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations

Gunawan, Ben, Button, Elise, Bates, Tracey, Nasato, Gillian and Wyld, David (2016). Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations

2015

Journal Article

High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq

Kondrashova,Olga, Love, Clare J., Lunke, Sebastian, Hsu, Arthur L., Waring, Paul M., Taylor, Graham R., Australian Ovarian Cancer Study (AOCS) Group, Chenevix-Trench, G. and Wyld, D. (2015). High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq. PLoS One, 10 (11) e0143006, 1-14. doi: 10.1371/journal.pone.0143006

High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq

2015

Journal Article

A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers

Burge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418

A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers

2015

Journal Article

A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services

Beesley, Vanessa L., Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David and Neale, Rachel E. (2015). A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. Psycho-Oncology, 25 (2), 150-157. doi: 10.1002/pon.3887

A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services

2015

Conference Publication

A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy

Kevat, D., Chen, M., Wyld, D., Fagermo, N. and Lust, K. (2015). A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy. RCOG World Congress 2015, 12–15 April, Brisbane, Queensland, Australia, Brisbane, Queensland, Australia, 12–15 April 2015. Chichester, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/1471-0528.13370

A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy

2015

Conference Publication

Patient understanding of research in a medical oncology setting

Roberts, Natasha, Ives, Amy, Wyld, David and Cubitt, Annette (2015). Patient understanding of research in a medical oncology setting. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

Patient understanding of research in a medical oncology setting

2015

Conference Publication

A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor

Michael, M., Pavlakis, N., Wyld, D., Link, E., Liauw, W., Kuru, N. and Hicks, R. (2015). A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385

A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor

2015

Journal Article

Describing patterns of care in pancreatic cancer a population-based study

Burmeister, Elizabeth A., O'Connell, Dianne L., Beesley, Vanessa L., Goldstein, David, Gooden, Helen M., Janda, Monika, Jordan, Susan J., Merrett, Neil D., Payne, Madeleine E., Wyld, David and Neale, Rachel E. (2015). Describing patterns of care in pancreatic cancer a population-based study. Pancreas, 44 (8), 1259-1265. doi: 10.1097/MPA.0000000000000384

Describing patterns of care in pancreatic cancer a population-based study

2015

Conference Publication

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)

Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)

2015

Conference Publication

Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study

Jan, H., Wyld, D. and Burge, M. (2015). Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, Mar 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385

Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study

2015

Conference Publication

Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer

Wyld, David, Gibson, Alexandra, Broom, Alex, Plage, Stefanie, Cubitt, Annette and Lwin, Zarnie (2015). Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer. COSA’s 42nd Annual Scientific Meeting. Rare Cancers, Hobart, TAS, Australia, 17-19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer

2014

Journal Article

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis

Beesley, Vanessa L., Green, Adele C., Wyld, David K., O'Rourke, Peter, Wockner, Leesa F., Defazio, Anna, Butow, Phyllis N., Price, Melanie A., Horwood, Keith R., Clavarino, Alexandra M. and Webb, Penelope M. (2014). Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Obstetrical and Gynecological Survey, 69 (5), 257-259. doi: 10.1097/01.ogx.0000450117.94530.01

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis

2014

Conference Publication

Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons

Wyeth, Holly, Chan, Bryan, Burge, Matthew, Wyld, David and Eastgate, Melissa (2014). Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, VIC Australia, 2-4 December 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons

2014

Conference Publication

Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital

2014

Conference Publication

Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospital

2014

Conference Publication

Assessment of long course chemoradiotherapy (Lccrt) in regards to completion of chemotherapy. The experience of a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Assessment of long course chemoradiotherapy (Lccrt) in regards to completion of chemotherapy. The experience of a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Assessment of long course chemoradiotherapy (Lccrt) in regards to completion of chemotherapy. The experience of a tertiary referral hospital

2014

Conference Publication

Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone

Chan, B. A., Wyld, D., Burge, M., Cuneo, R., Macfarlane, D. and Lee, K. (2014). Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG.

Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone

2014

Journal Article

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis

Beesley, Vanessa L., Green, Adele C., Wyld, David K., O'Rourke, Peter, Wockner, Leesa F., deFazio, Anna, Butow, Phyliss N., Price, Melanie A., Horwood, Keith R., Clavarino, Alexandra M., Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study - Quality of Life Study Investigators and Webb, Penelope M. (2014). Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. Gynecologic Oncology, 132 (1), 130-136. doi: 10.1016/j.ygyno.2013.10.004

Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis

2014

Conference Publication

Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital

2014

Conference Publication

Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospital

Christie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospital

Funding

Current funding

  • 2020 - 2026
    A new radio-imaging agent to guide targeted therapy for epithelial ovarian cancer
    NHMRC MRFF EPCDR - Ovarian Cancer Research
    Open grant

Past funding

  • 2020 - 2023
    PRoCESS: Pancreatic cancer Relatives Counselling and Education Support Service trial....(MRFF RCRDUN administered by QMIR)
    Queensland Institute of Medical Research
    Open grant

Supervision

Availability

Associate Professor David Wyld is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Examining real-world evidence for immune checkpoint inhibitor (PD-L1) treatment in advanced non small cell lung cancer (NSCLC): A population based data analysis in Queensland, Australia

    Associate Advisor

    Other advisors: Professor Jason Pole

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor David Wyld's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au